Endocrine Abstracts

Objective of our study was to investigate the renoprotective efficacy of valsartan and enalapril depending on the genetic polymorphisms of the angiotensinic system.Material and methods: In 32 type 2 diabetic patients with microalbuminuria, DNA extraction and genotypization were performed. The studied polymorphism was A1166C of the AT1-receptor gene. Two types of antiangiotensinic drugs were used in order to reduce microalbuminuria: enalapril (20 mg/d) an...